Correlation Between Neoleukin Therapeutics and Evelo Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neoleukin Therapeutics and Evelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neoleukin Therapeutics and Evelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neoleukin Therapeutics and Evelo Biosciences, you can compare the effects of market volatilities on Neoleukin Therapeutics and Evelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neoleukin Therapeutics with a short position of Evelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neoleukin Therapeutics and Evelo Biosciences.

Diversification Opportunities for Neoleukin Therapeutics and Evelo Biosciences

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neoleukin and Evelo is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Neoleukin Therapeutics and Evelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Evelo Biosciences and Neoleukin Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neoleukin Therapeutics are associated (or correlated) with Evelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Evelo Biosciences has no effect on the direction of Neoleukin Therapeutics i.e., Neoleukin Therapeutics and Evelo Biosciences go up and down completely randomly.

Pair Corralation between Neoleukin Therapeutics and Evelo Biosciences

If you would invest  823.00  in Evelo Biosciences on August 28, 2024 and sell it today you would earn a total of  0.00  from holding Evelo Biosciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neoleukin Therapeutics  vs.  Evelo Biosciences

 Performance 
       Timeline  
Neoleukin Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Neoleukin Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Neoleukin Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Evelo Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Evelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Evelo Biosciences is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Neoleukin Therapeutics and Evelo Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neoleukin Therapeutics and Evelo Biosciences

The main advantage of trading using opposite Neoleukin Therapeutics and Evelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neoleukin Therapeutics position performs unexpectedly, Evelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evelo Biosciences will offset losses from the drop in Evelo Biosciences' long position.
The idea behind Neoleukin Therapeutics and Evelo Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Managers
Screen money managers from public funds and ETFs managed around the world
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Commodity Directory
Find actively traded commodities issued by global exchanges